Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals

BACKGROUND: Despite healthcare professionals (HCP) endorsing the clinical utility of pharmacogenomics testing, use in clinical practice is limited. AIMS: To assess HCP' perceptions of pharmacogenomic testing and identify barriers to implementation. METHODS: HCP involved in prescribing decisions...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearce, Angela, Terrill, Bronwyn, Alffenaar, Jan‐Willem, Patanwala, Asad E., Kummerfeld, Sarah, Day, Richard, Young, Mary‐Anne, Stocker, Sophie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541847/
https://www.ncbi.nlm.nih.gov/pubmed/35191159
http://dx.doi.org/10.1111/imj.15719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541847/
https://www.ncbi.nlm.nih.gov/pubmed/35191159
http://dx.doi.org/10.1111/imj.15719

Ejemplares similares